Defining Optimal Cutoff Scores for Cognitive Impairment Using Movement Disorder Society Task Force Criteria for Mild Cognitive Impairment in Parkinson's Disease

被引:100
|
作者
Goldman, Jennifer G. [1 ]
Holden, Samantha [1 ]
Bernard, Bryan [1 ]
Ouyang, Bichun [1 ]
Goetz, Christopher G. [1 ]
Stebbins, Glenn T. [1 ]
机构
[1] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
executive function; mild cognitive impairment; memory; neuropsychological tests; Parkinson's disease; MINI-MENTAL-STATE; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; DEMENTIA; INCIDENT; SUBTYPES; HISTORY; PROFILE; MEMORY; FALLS;
D O I
10.1002/mds.25655
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The recently proposed Movement Disorder Society (MDS) Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease (PD-MCI) represent a first step toward a uniform definition of PD-MCI across multiple clinical and research settings. However, several questions regarding specific criteria remain unanswered, including optimal cutoff scores by which to define impairment on neuropsychological tests. Seventy-six non-demented PD patients underwent comprehensive neuropsychological assessment and were classified as PD-MCI or PD with normal cognition (PD-NC). The concordance of PD-MCI diagnosis by MDS Task Force Level II criteria (comprehensive assessment), using a range of standard deviation (SD) cutoff scores, was compared with our consensus diagnosis of PD-MCI or PD-NC. Sensitivity, specificity, and positive and negative predictive values were examined for each cutoff score. PD-MCI subtype classification and distribution of cognitive domains impaired were evaluated. Concordance for PD-MCI diagnosis was greatest for defining impairment on neuropsychological tests using a 2 SD cutoff score below appropriate norms. This cutoff also provided the best discriminatory properties for separating PD-MCI from PD-NC compared with other cutoff scores. With the MDS PD-MCI criteria, multiple domain impairment was more frequent than single domain impairment, with predominant executive function, memory, and visuospatial function deficits. Application of the MDS Task Force PD-MCI Level II diagnostic criteria demonstrates good sensitivity and specificity at a 2 SD cutoff score. The predominance of multiple domain impairment in PD-MCI with the Level II criteria suggests not only influences of testing abnormality requirements, but also the widespread nature of cognitive deficits within PD-MCI. (c) 2013 International Parkinson and Movement Disorder Society
引用
收藏
页码:1972 / 1979
页数:8
相关论文
共 50 条
  • [41] Cognitive training interventions for dementia and mild cognitive impairment in Parkinson's disease
    Orgeta, Vasiliki
    McDonald, Kathryn R.
    Poliakoff, Ellen
    Hindle, John Vincent
    Clare, Linda
    Leroi, Iracema
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (02):
  • [42] Measuring mild cognitive impairment in patients with Parkinson's disease
    Marras, Connie
    Armstrong, Melissa J.
    Meaney, Christopher A.
    Fox, Susan
    Rothberg, Brandon
    Reginold, William
    Tang-Wai, David F.
    Gill, David
    Eslinger, Paul J.
    Zadikoff, Cindy
    Kennedy, Nancy
    Marshall, Fred J.
    Mapstone, Mark
    Chou, Kelvin L.
    Persad, Carol
    Litvan, Irene
    Mast, Benjamin T.
    Gerstenecker, Adam T.
    Weintraub, Sandra
    Duff-Canning, Sarah
    MOVEMENT DISORDERS, 2013, 28 (05) : 626 - 633
  • [43] Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
    Sasikumar, Sanskriti
    Strafella, Antonio P.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [44] Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
    Rimona S. Weil
    Alyssa A. Costantini
    Anette E. Schrag
    Current Neurology and Neuroscience Reports, 2018, 18
  • [45] Cognitive complaint in mild cognitive impairment and Alzheimer's disease
    Clement, Francis
    Belleville, Sylvie
    Gauthier, Serge
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2008, 14 (02) : 222 - 232
  • [46] Utility and Limitations of Addenbrooke's Cognitive Examination-Revised for Detecting Mild Cognitive Impairment in Parkinson's Disease
    Komadina, Natalie C.
    Terpening, Zoe
    Huang, Yue
    Halliday, Glenda M.
    Naismith, Sharon L.
    Lewis, Simon J. G.
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2011, 31 (05) : 349 - 357
  • [47] Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease
    Goldman, Jennifer G.
    Aggarwal, Neelum T.
    Schroeder, Cynthia D.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (05) : 425 - 443
  • [48] Characterizing Cognitive Impairment in Parkinson's Disease
    Bailey, Meagan
    Goldman, Jennifer G.
    SEMINARS IN NEUROLOGY, 2017, 37 (02) : 167 - 175
  • [49] Donepezil for mild cognitive impairment in Parkinson's disease
    Baik, Kyoungwon
    Kim, Seon Myeong
    Jung, Jin Ho
    Lee, Yang Hyun
    Chung, Seok Jong
    Yoo, Han Soo
    Ye, Byoung Seok
    Lee, Phil Hyu
    Sohn, Young H.
    Kang, Seung Wan
    Kang, Suk Yun
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [50] Mild cognitive impairment in Parkinson's disease
    Martinez-Horta, Saul
    Kulisevsky, Jaime
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (07) : 897 - 904